Expertise
Transplant immunobiology.
Clinical Areas: Islet cell transplantation
His research is focused on new modalities of immunosuppression that prevent islet allograft rejection and at the same time allow for long term islet allograft survival with fewer side effects.
In addition he is exploring the use of selected agents with a unique spectrum of anti-inflammatory, anti-apoptotic (Lisofylline , exenatide) and beta cell enhancing properties (exenatide or similar compounds) to improve beta cell function and viability as well as islet engraftment and long-term function, therefore maximizing functional islet mass before and after transplantation in patients with Type 1 diabetes.
Links
Organizational Affiliations
Education
University of Puerto Rico
MD